Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Kumi Izawa was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Nov 06
ZACROS Corporation (TSE:7917) announces an Equity Buyback for 1,820,000 shares, representing 2.51% for ¥2,000 million. ZACROS Corporation (TSE:7917) announces a share repurchase program. Under the program, the company will repurchase up to 1,820,000 shares, representing 2.51% of the outstanding shares (excluding the treasury shares) for ¥2,000 million. The purpose of the program is to execute a flexible capital policy in response to changes in the business environment. The repurchase program is valid till June 30, 2026. As of September 30, 2025, the company had 72,489,828 issued shares (excluding treasury stock) and 4,581,212 shares in treasury. Annuncio • May 08
ZACROS Corporation, Annual General Meeting, Jun 20, 2025 ZACROS Corporation, Annual General Meeting, Jun 20, 2025. Annuncio • Feb 08
ZACROS Corporation (TSE:7917) announces an Equity Buyback for 500,000 shares, representing 2.69% for ¥2,000 million. ZACROS Corporation (TSE:7917) announces a share repurchase program. Under the program, the company will repurchase up to 500,000 shares, representing 2.69% of the outstanding shares (excluding the treasury shares) for ¥2,000 million. The purpose of the program is to implement a flexible capital policy aligned with changes in its business environment. The repurchase program is valid till September 30, 2025. As of December 31, 2024, the company had 18,607,448 issued shares (excluding treasury stock) and 660,312 shares in treasury. Buy Or Sell Opportunity • Nov 17
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 2.3% to €25.00. The fair value is estimated to be €31.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.1% over the last 3 years. Earnings per share has declined by 24%. Revenue is forecast to grow by 11% in 2 years. Earnings are forecast to grow by 51% in the next 2 years. New Risk • Aug 22
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 24% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Declared Dividend • Jul 25
Final dividend of JP¥63.00 announced Shareholders will receive a dividend of JP¥63.00. Ex-date: 27th September 2024 Payment date: 27th November 2024 Dividend yield will be 245%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (35% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 8.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 48% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Jun 25
Full year 2024 earnings released: EPS: JP¥241 (vs JP¥256 in FY 2023) Full year 2024 results: EPS: JP¥241 (down from JP¥256 in FY 2023). Revenue: JP¥136.2b (up 5.2% from FY 2023). Net income: JP¥4.53b (down 6.6% from FY 2023). Profit margin: 3.3% (down from 3.8% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Annuncio • May 11
Fujimori Kogyo Co., Ltd., Annual General Meeting, Jun 20, 2024 Fujimori Kogyo Co., Ltd., Annual General Meeting, Jun 20, 2024. Reported Earnings • May 10
Full year 2024 earnings released: EPS: JP¥241 (vs JP¥256 in FY 2023) Full year 2024 results: EPS: JP¥241 (down from JP¥256 in FY 2023). Revenue: JP¥136.2b (up 5.2% from FY 2023). Net income: JP¥4.53b (down 6.6% from FY 2023). Profit margin: 3.3% (down from 3.8% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Buy Or Sell Opportunity • May 10
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 11% to €26.80. The fair value is estimated to be €21.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has declined by 18%. Revenue is forecast to grow by 11% in 2 years. Earnings are forecast to grow by 109% in the next 2 years. Buy Or Sell Opportunity • Apr 11
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 9.2% to €26.20. The fair value is estimated to be €21.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has declined by 18%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 112% in the next 2 years. Buy Or Sell Opportunity • Mar 28
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 13% to €26.20. The fair value is estimated to be €21.62, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has declined by 18%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 112% in the next 2 years. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥42.00 per share Eligible shareholders must have bought the stock before 28 March 2024. Payment date: 21 June 2024. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.9%). Lower than average of industry peers (4.8%). Reported Earnings • Feb 09
Third quarter 2024 earnings released: JP¥16.11 loss per share (vs JP¥42.42 profit in 3Q 2023) Third quarter 2024 results: JP¥16.11 loss per share (down from JP¥42.42 profit in 3Q 2023). Revenue: JP¥35.8b (up 9.0% from 3Q 2023). Net loss: JP¥303.0m (down 138% from profit in 3Q 2023). Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 09
Second quarter 2024 earnings released: EPS: JP¥79.69 (vs JP¥59.39 in 2Q 2023) Second quarter 2024 results: EPS: JP¥79.69 (up from JP¥59.39 in 2Q 2023). Revenue: JP¥34.0b (up 3.4% from 2Q 2023). Net income: JP¥1.50b (up 33% from 2Q 2023). Profit margin: 4.4% (up from 3.4% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 14% per year. Annuncio • Nov 09
Fujimori Kogyo Co., Ltd. (TSE:7917) announces an Equity Buyback for 250,000 shares, representing 1.33% for ¥1,000 million. Fujimori Kogyo Co., Ltd. (TSE:7917) announces a share repurchase program. Under the program, the company will repurchase up to 250,000 shares, representing 1.33% of the outstanding shares (excluding the treasury shares) for ¥1,000 million. The purpose of the program is to carry out flexible capital policy in response to changes in the business environment. The repurchase program is valid till March 31, 2024. As of September 30, 2023, the company had 18,841,067 issued shares (excluding treasury stock) and 426,693 shares in treasury. Upcoming Dividend • Sep 21
Upcoming dividend of JP¥42.00 per share at 2.2% yield Eligible shareholders must have bought the stock before 28 September 2023. Payment date: 28 November 2023. Payout ratio is a comfortable 37% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (5.9%). Reported Earnings • Aug 09
First quarter 2024 earnings released: EPS: JP¥104 (vs JP¥131 in 1Q 2023) First quarter 2024 results: EPS: JP¥104 (down from JP¥131 in 1Q 2023). Revenue: JP¥31.9b (down 4.4% from 1Q 2023). Net income: JP¥1.95b (down 22% from 1Q 2023). Profit margin: 6.1% (down from 7.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 9% per year. Reported Earnings • Jun 22
Full year 2023 earnings released: EPS: JP¥256 (vs JP¥404 in FY 2022) Full year 2023 results: EPS: JP¥256 (down from JP¥404 in FY 2022). Revenue: JP¥129.4b (up 1.2% from FY 2022). Net income: JP¥4.85b (down 37% from FY 2022). Profit margin: 3.8% (down from 6.0% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • May 14
Full year 2023 earnings released: EPS: JP¥256 (vs JP¥404 in FY 2022) Full year 2023 results: EPS: JP¥256 (down from JP¥404 in FY 2022). Revenue: JP¥129.4b (up 1.2% from FY 2022). Net income: JP¥4.85b (down 37% from FY 2022). Profit margin: 3.8% (down from 6.0% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Annuncio • May 13
Fujimori Kogyo Co., Ltd., Annual General Meeting, Jun 20, 2023 Fujimori Kogyo Co., Ltd., Annual General Meeting, Jun 20, 2023. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥42.00 per share at 2.7% yield Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 20 June 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 2.7%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.7%). Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: JP¥42.41 (vs JP¥92.56 in 3Q 2022) Third quarter 2023 results: EPS: JP¥42.41 (down from JP¥92.56 in 3Q 2022). Revenue: JP¥32.9b (flat on 3Q 2022). Net income: JP¥806.0m (down 54% from 3Q 2022). Profit margin: 2.5% (down from 5.3% in 3Q 2022). Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 16
Second quarter 2023 earnings released: EPS: JP¥59.39 (vs JP¥95.10 in 2Q 2022) Second quarter 2023 results: EPS: JP¥59.39 (down from JP¥95.10 in 2Q 2022). Revenue: JP¥32.9b (up 7.5% from 2Q 2022). Net income: JP¥1.13b (down 38% from 2Q 2022). Profit margin: 3.4% (down from 5.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 9 non-independent directors. Independent Outside Director Manabu Sakai was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 10
Second quarter 2023 earnings released: EPS: JP¥59.38 (vs JP¥95.10 in 2Q 2022) Second quarter 2023 results: EPS: JP¥59.38 (down from JP¥95.10 in 2Q 2022). Revenue: JP¥32.9b (up 7.5% from 2Q 2022). Net income: JP¥1.13b (down 38% from 2Q 2022). Profit margin: 3.4% (down from 5.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Annuncio • Nov 09
Fujimori Kogyo Co., Ltd. (TSE:7917) announces an Equity Buyback for 270,000 shares, representing 1.4% for ¥942.95 million. Fujimori Kogyo Co., Ltd. (TSE:7917) announces a share repurchase program. Under the program, the company will repurchase up to 270,000 shares, representing 1.40% of its issued share capital (excluding treasury stock), for a total purchase price of ¥942.95 million. The purpose of the program is to enable flexible capital policies in response to changes in the business environment. The program will continue through February 28, 2023. As of September 30, 2022, the company had 19,267,760 issued shares (excluding treasury stock) and 185,906 treasury shares. Upcoming Dividend • Sep 22
Upcoming dividend of JP¥42.00 per share Eligible shareholders must have bought the stock before 29 September 2022. Payment date: 29 November 2022. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (5.1%). Lower than average of industry peers (6.1%). Reported Earnings • Aug 05
First quarter 2023 earnings released: EPS: JP¥131 (vs JP¥126 in 1Q 2022) First quarter 2023 results: EPS: JP¥131 (up from JP¥126 in 1Q 2022). Revenue: JP¥33.3b (up 6.8% from 1Q 2022). Net income: JP¥2.50b (up 4.0% from 1Q 2022). Profit margin: 7.5% (down from 7.7% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.3%, compared to a 3.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 22
Full year 2022 earnings released: EPS: JP¥404 (vs JP¥382 in FY 2021) Full year 2022 results: EPS: JP¥404 (up from JP¥382 in FY 2021). Revenue: JP¥127.8b (up 9.0% from FY 2021). Net income: JP¥7.69b (up 5.7% from FY 2021). Profit margin: 6.0% (down from 6.2% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.1%, compared to a 7.0% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Reported Earnings • May 13
Full year 2022 earnings released: EPS: JP¥404 (vs JP¥382 in FY 2021) Full year 2022 results: EPS: JP¥404 (up from JP¥382 in FY 2021). Revenue: JP¥127.8b (up 9.0% from FY 2021). Net income: JP¥7.69b (up 5.7% from FY 2021). Profit margin: 6.0% (down from 6.2% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 1.3%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Annuncio • May 13
Fujimori Kogyo Co., Ltd., Annual General Meeting, Jun 17, 2022 Fujimori Kogyo Co., Ltd., Annual General Meeting, Jun 17, 2022. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 9 non-independent directors. Independent Outside Director Manabu Sakai was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Apr 08
Fujimori Kogyo Co., Ltd. to Report Fiscal Year 2022 Results on May 11, 2022 Fujimori Kogyo Co., Ltd. announced that they will report fiscal year 2022 results on May 11, 2022 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥40.00 per share Eligible shareholders must have bought the stock before 30 March 2022. Payment date: 21 June 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of German dividend payers (3.6%). Lower than average of industry peers (4.7%). Reported Earnings • Feb 10
Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Third quarter 2022 results: EPS: JP¥92.56 (up from JP¥85.54 in 3Q 2021). Revenue: JP¥33.1b (up 16% from 3Q 2021). Net income: JP¥1.77b (up 8.5% from 3Q 2021). Profit margin: 5.3% (down from 5.7% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 11%. Over the next year, revenue is forecast to stay flat compared to a 6.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Annuncio • Feb 10
Fujimori Kogyo Co., Ltd. (TSE:7917) announces an Equity Buyback for 50,000 shares, representing 0.26% for ¥208.25 million. Fujimori Kogyo Co., Ltd. (TSE:7917) announces a share repurchase program. Under the program, the company will repurchase up to 50,000 shares, representing 0.26% of its share capital, for ¥208.25 million. The shares will be repurchased at a price of ¥4,165 per share. The purpose of the program is to carry out agile capital policies in response to changes in the business environment. As of December 31, 2021, the company had 19,080,400 shares in issue and 187,360 shares in treasury. Reported Earnings • Nov 11
Second quarter 2022 earnings released: EPS JP¥95.10 (vs JP¥83.28 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥30.6b (up 5.1% from 2Q 2021). Net income: JP¥1.81b (up 14% from 2Q 2021). Profit margin: 5.9% (up from 5.4% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 14% per year. Upcoming Dividend • Sep 22
Upcoming dividend of JP¥40.00 per share Eligible shareholders must have bought the stock before 29 September 2021. Payment date: 30 November 2021. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.7%). Reported Earnings • Jun 24
Full year 2021 earnings released: EPS JP¥382 (vs JP¥280 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥117.3b (up 2.6% from FY 2020). Net income: JP¥7.28b (up 37% from FY 2020). Profit margin: 6.2% (up from 4.7% in FY 2020). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 15
Full year 2021 earnings released: EPS JP¥382 (vs JP¥280 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥117.3b (up 2.6% from FY 2020). Net income: JP¥7.28b (up 37% from FY 2020). Profit margin: 6.2% (up from 4.7% in FY 2020). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Upcoming Dividend • Mar 24
Upcoming dividend of JP¥35.00 per share Eligible shareholders must have bought the stock before 30 March 2021. Payment date: 22 June 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%). Is New 90 Day High Low • Feb 25
New 90-day low: €33.40 The company is down 8.0% from its price of €36.20 on 27 November 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €48.28 per share. Reported Earnings • Feb 12
Third quarter 2021 earnings released: EPS JP¥85.54 (vs JP¥81.18 in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: JP¥28.6b (down 1.1% from 3Q 2020). Net income: JP¥1.63b (up 5.4% from 3Q 2020). Profit margin: 5.7% (up from 5.3% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year. Analyst Estimate Surprise Post Earnings • Feb 12
Revenue misses expectations Revenue missed analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 5.0%, compared to a 5.1% growth forecast for the Chemicals industry in Germany. Is New 90 Day High Low • Nov 28
New 90-day high: €36.20 The company is up 20% from its price of €30.20 on 28 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Nov 19
Second quarter 2021 earnings released: EPS JP¥83.28 The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: JP¥29.1b (down 1.0% from 2Q 2020). Net income: JP¥1.59b (up 11% from 2Q 2020). Profit margin: 5.4% (up from 4.9% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Analyst Estimate Surprise Post Earnings • Nov 19
Revenue beats expectations Revenue exceeded analyst estimates by 0.8%. Over the next year, revenue is forecast to grow 4.0%, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Reported Earnings • Nov 11
Second quarter 2021 earnings released: EPS JP¥83.28 The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: JP¥29.1b (down 1.0% from 2Q 2020). Net income: JP¥1.59b (up 11% from 2Q 2020). Profit margin: 5.4% (up from 4.9% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 8% per year. Analyst Estimate Surprise Post Earnings • Nov 11
Revenue beats expectations Revenue exceeded analyst estimates by 0.8%. Over the next year, revenue is forecast to grow 4.0%, compared to a 3.1% growth forecast for the Chemicals industry in Germany.